What is Veerhealth Care share price return in the past 10 years?

Veerhealth Care Ltd share price has appreciated 7.5% annually (CAGR) over the past ten years.

Veerhealth Care Ltd - Stock Valuation and Financial Performance

Name: Veerhealth Care
Brand: Veerhealth Care

BSE: 511523 | NSE: NIYATILEAS | Pharmaceuticals & Drugs | Small Cap

Place order

Veerhealth Care Share Price

₹20.98 -0.42 -1.96%
as on 19-Apr'24 16:01

DeciZen - make an informed investing decision on Veerhealth Care

Based on:

Data

M-Cap below 100cr DeciZen not available

Veerhealth Care stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

21.30

Market Cap:

42 Cr.

52-wk low:

9.4

52-wk high:

30.1

Is Veerhealth Care Ltd an attractive stock to invest in?

1. Is Veerhealth Care Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Veerhealth Care Ltd is a below average quality company.

2. Is Veerhealth Care Ltd undervalued or overvalued?

The key valuation ratios of Veerhealth Care Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Veerhealth Care Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Veerhealth Care Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Veerhealth Care:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
ROCE % ⓘ	0.2%	-0.6%	0.7%	0.7%	1.4%	1.3%	3%	3.3%	-0.1%	9%	-
Value Creation Index ⓘ	-1.0	-1.0	-1.0	-1.0	-0.9	-0.9	-0.8	-0.8	-1.0	-0.4	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	3	1.3	2.1	1.9	5.2	6	11.7	10.6	9.6	13.3	14
Sales YoY Gr.	-	-55.5%	59.4%	-9.4%	169.3%	15.7%	96.2%	-9.8%	-9%	37.8%	-
Adj EPS ⓘ	0	-0.1	0	0	0.1	0.1	0.2	0.3	-0.1	0.8	1
YoY Gr.	-	-500%	NA	100%	400%	10%	109.1%	17.4%	-118.5%	NA	-
BVPS (₹) ⓘ	9.2	9.2	9.2	9.3	9.5	9.6	9.9	10.1	10.1	10.7	11.2
Adj Net Profit ⓘ	0	-0.1	0	0	0.1	0.2	0.3	0.4	-0.1	1.6	2
Cash Flow from Ops. ⓘ	3.9	-3.7	0	1.7	1.8	2	-0.4	1	1.8	-0.7	-
Debt/CF from Ops. ⓘ	0	-0.3	-3604	-0.1	0.7	0.5	-7	1.7	0	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	18%	20.8%	4.2%	37.8%
Adj EPS ⓘ	50.5%	51.2%	50.9%	NA
BVPSⓘ	1.8%	2.6%	2.6%	6.6%
Share Price	7.5%	38%	61.8%	102.3%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
Return on Equity % ⓘ	0.2	-0.9	0.1	0.2	1.1	1.2	2.4	2.7	-0.5	9	9
Op. Profit Mgn % ⓘ	-16.1	-11.8	-1	-18.9	-2.4	7.4	5.8	-0.6	-8.6	3.7	8.6
Net Profit Mgn % ⓘ	0.9	-8.6	0.4	1.2	2.7	2.6	2.7	3.6	-0.8	11.9	14.1
Debt to Equity ⓘ	0	0.1	0.1	-0	0.1	0.1	0.2	0.1	0	0	-
Working Cap Days ⓘ	1,337	2,718	1,943	2,072	685	525	262	305	348	259	121
Cash Conv. Cycle ⓘ	36	195	274	374	125	42	18	64	75	71	107

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 9.00%

Net Profit is growing at healthy rate in last 3 years 50.88%

Sales growth is good in last 4 quarters at 28.14%

Sales growth has been subdued in last 3 years 4.20%

Latest Financials - Veerhealth Care Ltd.

	Standalone	Consolidated
TTM EPS (₹)	1	-
TTM Sales (₹ Cr.)	14	-
BVPS (₹.) ⓘ	11.2	-
Reserves (₹ Cr.) ⓘ	2	-
P/BV ⓘ	1.87	-
PE ⓘ	21.30	-

From the Market
52 Week Low / High (₹)	9.35 / 30.10
All Time Low / High (₹)	0.25 / 43.75
Market Cap (₹ Cr.)	42
Equity (₹ Cr.)	20
Face Value (₹)	10
Industry PE ⓘ	47.2

Management X-Ray of Veerhealth Care:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Veerhealth Care

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Veerhealth Care

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Sales	2.99	1.33	2.12	1.92	5.17	5.98	11.73	10.58	9.63	13.27
Operating Expenses ⓘ	3.47	1.49	2.14	2.28	5.29	5.54	11.05	10.64	10.46	12.78
Manufacturing Costs	0.01	0.10	0.10	0.12	0.19	0.18	0.93	1.31	0.93	0.61
Material Costs	3.13	0.73	0.92	1.16	3.68	3.79	7.88	7.52	6.92	9.23
Employee Cost	0.22	0.43	0.47	0.58	0.57	0.47	0.80	0.83	0.88	0.90
Other Costs ⓘ	0.10	0.23	0.66	0.42	0.85	1.11	1.44	0.99	1.73	2.04
Operating Profit ⓘ	-0.48	-0.16	-0.02	-0.36	-0.12	0.44	0.68	-0.06	-0.83	0.49
Operating Profit Margin (%)	-16.1%	-12.2%	-1.0%	-18.9%	-2.4%	7.4%	5.8%	-0.6%	-8.6%	3.7%
Other Income ⓘ	0.54	0.49	0.38	0.72	0.72	0.29	0.48	1.33	1.68	1.25
Interest ⓘ	0	0.06	0.13	0.10	0.07	0.03	0.19	0.22	0.09	0
Depreciation ⓘ	0.02	0.11	0.21	0.23	0.27	0.32	0.32	0.47	0.52	0.62
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	0.04	0.16	0.02	0.03	0.25	0.38	0.65	0.58	0.24	1.12
Tax ⓘ	0.01	0.10	0.01	0.01	0.11	0.22	0.33	0.20	0.31	-0.47
Profit After Tax	0.03	0.06	0.01	0.02	0.14	0.16	0.32	0.38	-0.07	1.58
PAT Margin (%)	0.9%	4.3%	0.4%	1.2%	2.7%	2.6%	2.7%	3.6%	-0.8%	11.9%
Adjusted EPS (₹)	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.3	-0.1	0.8
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Equity and Liabilities
Shareholders Fund	12.74	12.80	12.82	12.85	13.10	13.28	13.76	14.04	13.95	21.43
Share Capital ⓘ	6.93	6.93	6.93	6.93	6.93	6.93	6.93	6.93	6.93	10
Reserves ⓘ	5.81	5.86	5.88	5.92	6.17	6.35	6.82	7.11	7.02	11.43
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	0	1.01	1.08	-0.17	1.21	0.94	2.48	1.73	0	0
Long Term Debt	0	0.65	0.67	0.44	0.21	0	2.04	1.41	0	0
Short Term Debt	0	0.36	0.41	-0.61	1.01	0.94	0.44	0.32	0	0
Trade Payables	0.09	0.11	0.08	0.22	0.19	1.57	0.84	0.92	2.32	0.55
Others Liabilities ⓘ	0.08	0.13	0.14	0.16	0.23	0.36	0.91	2.04	3.88	3.27
Total Liabilities ⓘ	12.92	14.04	14.12	13.06	14.74	16.16	17.98	18.73	20.15	25.25
Fixed Assets
Gross Block	4.96	2.23	3.07	3.11	6.41	6.62	10.88	11.37	12.96	15.05
Accumulated Depreciation	0.06	0.16	0.36	0.59	0.86	1.16	1.43	1.89	2.42	3.04
Net Fixed Assetsⓘ	4.90	2.07	2.71	2.52	5.54	5.46	9.45	9.48	10.54	12.01
CWIP ⓘ	0	0	0	0	0.24	2.19	0	0	0	0
Investmentsⓘ	0	0	0	0	0	0	0	0	0	0
Inventories	0.10	0.46	1.12	1.53	0.94	0.84	1.23	1.66	2.12	2.61
Trade Receivables	0.08	0.93	0.89	0.61	0.92	0.74	0.94	1.54	1.54	1.84
Cash Equivalents	-0.01	0.11	0.10	0.02	0.08	0.18	0.02	0.10	0.40	3.61
Others Assetsⓘ	7.85	10.47	9.30	8.37	7.02	6.75	6.35	5.94	5.54	5.19
Total Assets ⓘ	12.92	14.04	14.12	13.06	14.74	16.16	17.98	18.73	20.15	25.25

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Cash Flow From Operating Activity ⓘ	3.88	-3.73	0	1.69	1.76	1.98	-0.36	1	1.81	-0.70
PBT ⓘ	0.04	0.16	0.02	0.03	0.25	0.38	0.65	0.47	0.26	1.05
Adjustment ⓘ	-0.53	-0.48	-0.27	-0.07	-0.09	0.32	0.21	0.37	0.10	0.53
Changes in Working Capital ⓘ	4.37	-3.48	0.24	0.95	1.7	1.41	-1.15	0.39	1.49	-2.08
Tax Paid ⓘ	0	0.07	0	0.78	-0.10	-0.13	-0.06	-0.23	-0.04	-0.20
Cash Flow From Investing Activity ⓘ	-4.26	3.85	-0.01	-0.44	-3.02	-1.90	-1.67	-0.09	-1.09	-1.79
Capex	-4.76	2.96	-0.76	-0.03	-3.54	-2.19	-2.12	-0.50	-1.58	-2.09
Net Investments	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0.51	0.89	0.75	-0.40	0.52	0.29	0.46	0.41	0.49	0.30
Cash Flow From Financing Activityⓘ	0	0	0	-1.33	1.31	0.02	1.85	-0.83	-0.42	5.69
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	5.90
Net Proceeds from Borrowing ⓘ	0	0	0	-0.21	-0.23	-0.21	2.04	-0.63	-1.41	0
Interest Paid ⓘ	0	0	0	-0.10	-0.07	-0.03	-0.19	-0.22	-0.09	-0.14
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	-1.02	1.62	0.27	0	0.02	1.08	-0.06
Net Cash Flow ⓘ	-0.38	0.12	-0.01	-0.08	0.06	0.10	-0.17	0.09	0.30	3.21

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Ratios
ROE (%)	0.2	0.45	0.07	0.18	1.06	1.2	2.35	2.73	-0.53	8.94
ROCE (%)	0.31	1.62	1.13	1	2.38	2.89	5.5	4.97	2.17	6.32
Asset Turnover Ratio	0.22	0.1	0.15	0.14	0.37	0.39	0.69	0.58	0.5	0.58
PAT to CFO Conversion(x)	129.33	-62.17	0	84.5	12.57	12.38	-1.13	2.63	N/A	-0.44
Working Capital Days
Receivable Days	110	138	152	142	54	51	26	43	59	46
Inventory Days	37	76	133	253	87	54	32	50	72	65
Payable Days	105	49	37	47	20	85	56	43	85	57

Veerhealth Care Ltd Stock News

Veerhealth Care Ltd FAQs

What is the share price of Veerhealth Care?

Company share prices are keep on changing according to the market conditions. The closing price of Veerhealth Care on 19-Apr-2024 16:01 is ₹20.98.

What is the market cap of Veerhealth Care?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 19-Apr-2024 16:01 the market cap of Veerhealth Care stood at ₹41.96.

What is the P/E ratio of Veerhealth Care?

The latest P/E ratio of Veerhealth Care as of 19-Apr-2024 16:01 is 21.30.

What is the P/B ratio of Veerhealth Care?

The latest P/B ratio of Veerhealth Care as of 19-Apr-2024 16:01 is 1.87.

What is the 52-week high and low of Veerhealth Care?

The 52-week high of Veerhealth Care is ₹30.10 and the 52-week low is ₹9.35.

What is the TTM revenue of Veerhealth Care?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Veerhealth Care is ₹14.01 ( Cr.) .

About Veerhealth Care Ltd

Veerhealth Care (Formerly known as Niyati Industries) was originally incorporated on July 10, 1992 as Niyati Leasing Limited. From July 15, 1993 the Company had begun the business in the field of Investment and Finance.

In 2013, the management of the company decided to diversify the business activities and changed its main object to Pharma sector and new name of the company is VeerHealth Care. In 2020, the company started operations in cosmetic manufacturing.

The company produces Intensive research based quality products with Expert guidance and enormous experience of renowned Vaid of Mumbai, Dr. Vinod C. Mehta, an Ayurvedic practioner since 30 years and Dr. Rajiv Bhirud, anexpert in formulations of cosmetic and personal care products.

The company is well-equipped with state-of-the-art manufacturing facilities and skilled personnel to ensure optimum utilization of resources with the best quality product.

Business area of the company

The company is engaged in the business of trading and manufacturing and marketing research-based Ayurvedic medicines.

Products of the company